Sphera Funds Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $6.58M | Buy |
30,256
+5,000
| +20% | +$1.11M | 1.05% | 35 |
|
|
2025
Q4 | $5.77M | Hold |
25,256
| – | – | 1.12% | 37 |
|
|
2025
Q3 | $5.85M | Hold |
25,256
| – | – | 1.23% | 23 |
|
|
2025
Q2 | $4.69M | Sell |
25,256
-5,000
| -17% | -$929K | 1.1% | 29 |
|
|
2025
Q1 | $6.34M | Sell |
30,256
-4,000
| -12% | -$778K | 1.46% | 17 |
|
|
2024
Q4 | $6.09M | Sell |
34,256
-3,744
| -10% | -$688K | 1.1% | 30 |
|
|
2024
Q3 | $7.5M | Hold |
38,000
| – | – | 1.19% | 28 |
|
|
2024
Q2 | $6.52M | Hold |
38,000
| – | – | 0.89% | 38 |
|
|
2024
Q1 | $6.92M | Sell |
38,000
-8,000
| -17% | -$1.38M | 0.97% | 36 |
|
|
2023
Q4 | $7.13M | Hold |
46,000
| – | – | 1.15% | 31 |
|
|
2023
Q3 | $6.86M | Sell |
46,000
-10,000
| -18% | -$1.47M | 1.25% | 24 |
|
|
2023
Q2 | $7.54M | Sell |
56,000
-7,000
| -11% | -$1.03M | 1.18% | 26 |
|
|
2023
Q1 | $10M | Buy |
63,000
+3,000
| +5% | +$459K | 1.68% | 17 |
|
|
2022
Q4 | $9.7M | Sell |
60,000
-102,285
| -63% | -$15.7M | 2.08% | 11 |
|
|
2022
Q3 | $21.8M | Sell |
162,285
-56,100
| -26% | -$8.05M | 3.02% | 8 |
|
|
2022
Q2 | $33.4M | Buy |
218,385
+27,391
| +14% | +$4.19M | 3.58% | 7 |
|
|
2022
Q1 | $31M | Sell |
190,994
-273,200
| -59% | -$39.7M | 4.38% | 5 |
|
|
2021
Q4 | $62.9M | Sell |
464,194
-132,100
| -22% | -$15.6M | 6.91% | 1 |
|
|
2021
Q3 | $64.3M | Buy |
596,294
+230,100
| +63% | +$26.3M | 5.4% | 3 |
|
|
2021
Q2 | $41.2M | Sell |
366,194
-233,306
| -39% | -$26.3M | 2.79% | 11 |
|
|
2021
Q1 | $64.9M | Buy |
599,500
+259,500
| +76% | +$27.8M | 4.98% | 3 |
|
|
2020
Q4 | $36.4M | Sell |
340,000
-450,000
| -57% | -$43.2M | 3.23% | 8 |
|
|
2020
Q3 | $69.2M | Buy |
790,000
+55,402
| +8% | +$5.22M | 6.8% | 2 |
|
|
2020
Q2 | $72.1M | Buy |
734,598
+569,598
| +345% | +$50.2M | 6.78% | 2 |
|
|
2020
Q1 | $12.6M | Buy |
+165,000
| New | +$14.1M | 1.57% | 15 |
|
|
2016
Q1 | – | Sell |
-362,000
| Closed | -$21.4M | – | 90 |
|
|
2015
Q4 | $21.4M | Buy |
362,000
+35,000
| +11% | +$2.02M | 3.14% | 8 |
|
|
2015
Q3 | $17.8M | Sell |
327,000
-80,000
| -20% | -$5.21M | 2.27% | 10 |
|
|
2015
Q2 | $27.3M | Hold |
407,000
| – | – | 2.68% | 7 |
|
|
2015
Q1 | $23.8M | Buy |
+407,000
| New | +$24.6M | 2.48% | 8 |
|
|
2014
Q4 | – | Sell |
-403,550
| Closed | -$23.3M | – | 126 |
|
|
2014
Q3 | $23.3M | Buy |
+403,550
| New | +$22.4M | 2.88% | 8 |
|
Other funds holding ABBV
VCM
VPM
Sphera Funds Management's ABBV Position: Q1 2026 in Review
Sphera Funds Management increased its AbbVie (ABBV) stake by 20% in Q1 2026, buying an estimated $1.11M and bringing the position to 30,256 shares worth $6.58M. The position accounts for 1.05% of the portfolio, ranked #35.
Sphera Funds Management first reported a position in ABBV in Q3 2014 and has held it in 30 quarters since. The position peaked at $72.1M in Q2 2020. 4,080 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.
- Sphera Funds Management held 30,256 shares of AbbVie worth $6.58M as of Q1 2026.
- Sphera Funds Management bought 5,000 AbbVie shares in Q1 2026, an estimated $1.11M.
- AbbVie made up 1.05% of Sphera Funds Management's portfolio in Q1 2026, its #35 holding.
- Sphera Funds Management first reported a position in AbbVie in Q3 2014 and has held it in 30 quarters since.
- Sphera Funds Management's AbbVie position peaked at $72.1M in Q2 2020.
- 4,080 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.
Based on Sphera Funds Management's 13F filing for Q1 2026, filed 15 May 2026.